Market Overview

McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23

McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $23 and maintains its Buy rating.

Posted-In: mcnicoll lewis vlakPrice Target Intraday Update Analyst Ratings


Related Articles (AMAG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters